The Lancet. Respiratory medicine
Journal
Overview
publication venue for
-
Smoking and e-cigarette use: key variables in testing IgA-oriented intranasal vaccines..
10.
2022
-
Moving beyond usual interstitial pneumonia to define progressive fibrotic interstitial lung disease..
9.
2021
-
Airway mucin MUC5AC and MUC5B concentrations and the initiation and progression of chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort..
9.
2021
-
Lung function decline in former smokers and low-intensity current smokers: a secondary data analysis of the NHLBI Pooled Cohorts Study..
8.
2019
-
Riociguat for idiopathic interstitial pneumonia-associated pulmonary hypertension (RISE-IIP): a randomised, placebo-controlled phase 2b study..
7.
2019
-
Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial..
7.
2019
-
Use of a molecular classifier to identify usual interstitial pneumonia in conventional transbronchial lung biopsy samples: a prospective validation study..
7.
2019
-
Increased monocyte count as a cellular biomarker for poor outcomes in fibrotic diseases: a retrospective, multicentre cohort study..
7.
2019
-
Perioperative mortality and morbidity after sublobar versus lobar resection for early-stage non-small-cell lung cancer: post-hoc analysis of an international, randomised, phase 3 trial (CALGB/Alliance 140503)..
6.
2018
-
Triple therapy with budesonide/glycopyrrolate/formoterol fumarate with co-suspension delivery technology versus dual therapies in chronic obstructive pulmonary disease (KRONOS): a double-blind, parallel-group, multicentre, phase 3 randomised controlled trial..
6.
2018
-
Laparoscopic anti-reflux surgery for the treatment of idiopathic pulmonary fibrosis (WRAP-IPF): a multicentre, randomised, controlled phase 2 trial..
6.
2018
-
Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort..
5.
2017
-
Validation of a 52-gene risk profile for outcome prediction in patients with idiopathic pulmonary fibrosis: an international, multicentre, cohort study..
5.
2017
-
Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort..
5.
2017
-
Immune plasma for the treatment of severe influenza: an open-label, multicentre, phase 2 randomised study..
5.
2017
-
Efficacy of simtuzumab versus placebo in patients with idiopathic pulmonary fibrosis: a randomised, double-blind, controlled, phase 2 trial..
5.
2016
-
Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial..
4.
2016
-
Molecular mechanisms underlying variations in lung function: a systems genetics analysis..
3.
2015
-
Association of hospital admission and forced vital capacity endpoints with survival in patients with idiopathic pulmonary fibrosis: analysis of a pooled cohort from three clinical trials..
3.
2015
-
ECMO as an emergency medical countermeasure..
2.
2014
-
RETRACTED: Effect of early versus late or no tracheostomy on mortality of critically ill patients receiving mechanical ventilation: a systematic review and meta-analysis.
2014
-
Lung microbiome and disease progression in idiopathic pulmonary fibrosis: an analysis of the COMET study..
2.
2014
-
Diagnosis of idiopathic pulmonary fibrosis with high-resolution CT in patients with little or no radiological evidence of honeycombing: secondary analysis of a randomised, controlled trial..
2.
2014
-
Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials..
1.
2013
-
Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study..
1.
2013
-
Once-daily inhaled fluticasone furoate and vilanterol versus vilanterol only for prevention of exacerbations of COPD: two replicate double-blind, parallel-group, randomised controlled trials..
1.
2013
-
GOLD 2011 disease severity classification in COPDGene: a prospective cohort study..
1.
2012
-
The elusive goal of COVID-19 vaccine immunity.
2022
-
Intensive care unit provision at the end of life: miles travelled, miles to go.
2019
-
Compelling evidence for the efficacy of α1-antitrypsin augmentation treatment for α1-antitrypsin deficiency.
2016
-
Serum procalcitonin and the admission decision in CAP.
2016
-
Targeted therapy outcomes in RET-rearranged lung cancers: drug or driver?
2016
-
Long-acting bronchodilators in COPD: an evolving story.
2013
-
Perplexing mortality data from triple therapy trials in COPD - Author's reply.
2021
-
Diagnostic criteria for idiopathic pulmonary fibrosis - Authors' reply.
2018
-
GOLD COPD categories are not fit for purpose in primary care--authors' reply.
2013
-
Progressive fibrosing interstitial lung disease: clinical uncertainties, consensus recommendations, and research priorities.
2020
-
Longitudinal lung function and gas transfer in individuals with idiopathic pulmonary fibrosis: a genome-wide association study.
2022
-
Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper.
2017
-
The diagnosis of idiopathic pulmonary fibrosis: current and future approaches.
2016
-
Meeting the challenge of COPD care delivery in the USA: a multiprovider perspective.
2016
Identity
ISO Abbreviation
Linking ISSN
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)